Internal Medicine, Endocrinology, Diabetes, & Metabolism · Riverside, CA
NPI
1376984351
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
10800 Magnolia Ave
Riverside, CA, 92505
Phone (951) 353-7373
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,233
23 services
Medicare patients, 2024
13
Average age 61
Drug cost, 2024
$740K
2,791 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Hadi Harati prescribed most often to Medicare patients was Ozempic (Semaglutide), with 297 prescriptions and refills. In total Hadi Harati wrote 2,791 Medicare prescriptions that cost $740K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 297 | 316 | 66 | $232K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 238 | 415 | 100 | $5,215 |
| Levothyroxine Sodium Generic | 201 | 636 | 59 | $3,692 |
| Jardiance Empagliflozin | 164 | 432 | 64 | $73K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 117 | 282 | 56 | $29K |
| Insulin Glargine-Yfgn Generic | 115 | 306 | 56 | $13K |
| Methimazole Generic | 109 | 313 | 36 | $1,610 |
| Humalog Insulin Lispro | 96 | 259 | 35 | $23K |
| Testosterone Generic | 76 | 149 | 28 | $5,942 |
| Humalog Kwikpen U-100 Insulin Lispro | 71 | 167 | 29 | $22K |
| Humulin R Insulin Regular, Human | 62 | 163 | 28 | $8,701 |
| Metformin Hcl Generic | 59 | 156 | 22 | $639 |
| Metformin Hcl Er Metformin Hcl | 58 | 129 | 22 | $491 |
| Victoza 2-Pak Liraglutide | 56 | 67 | 32 | $44K |
| Pioglitazone Hcl Generic | 53 | 176 | 20 | $629 |
Brand drugs: 1,342 claims; generic drugs: 1,050 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Hadi Harati were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.